Over 350 million Peripheral IV Catheters are sold in the US each year, with over 90% of hospital patients getting vital care through them.
Yet vascular access device failure is pervasive. Patients often complain of multiple catheter insertion attempts, and published data reveal up to 53% of PIVCs fail before therapy ends.
Traditional IV Catheter designs often lead to blood exposure, vein damage, and fluid leakage at the vein entry site, which can all contribute to device failure and patient harm.
I-V Access Technology (IVAT) has created two innovative design platforms: VenaValve® – Our BC-X® Multi-Access Blood Control Valve, and VenaSave® – Our unique, three layer Vein Preservation system. Both are designed to reduce the common problems with IV Access.
* Helm RE, Klausner JD, Klemperer JD, et al. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs 2015;38:189–203